US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
FDA issues recalls on at least 16 food and drug items in September. Here's a list
The FDA has removed the following items from store shelves this September, including pet food, baby powder and Lactaid.
FDA Recalls Gluten-Free Cake and Gives Risk Classification
The "mini raspberry lemon coffee cake" was recalled due to potentially containing undeclared wheat flour and walnuts.
MedPage Today1d
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D
The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once ...
Medscape1d
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...
Massive Egg Recall: FDA Warns of Highest Risk Level for Salmonella Contamination
The FDA has updated a major recall involving eggs from those two brands and now "Happy Quackers Farm," categorizing it as a ...
FDA now weighing approval of first new sunscreen ingredient in decades
An FDA proposal from 2019 floated pulling the approvals for more than a dozen sunscreen ingredients. Only two sunscreen ingredients — zinc oxide and titanium dioxide — would be able to keep their ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Bristol Myers wins US FDA approval for new type of schizophrenia drug
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
Targeted Oncology51m
September 2024 FDA Roundup: Key Decisions Drive Oncology Forward
On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...
FierceBiotech3h
FDA elevates Philips recall of hospital, home ventilator software
The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ...